Liver transplantation for primary hepatic malignancies of childhood: The UNOS experience

被引:16
作者
Hamilton, Emma C. [1 ,2 ]
Balogh, Julius [3 ,4 ]
Nguyen, Duc T. [5 ]
Graviss, Edward A. [5 ,6 ]
Heczey, Andras A. [7 ,8 ]
Austin, Mary T. [1 ,2 ,9 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, McGovern Med Sch, Houston, TX 77030 USA
[2] Univ Texas Hlth Sci Ctr Houston, Ctr Surg Trials & Evidence Based Practice, McGovern Med Sch, Houston, TX 77030 USA
[3] Univ Texas Hlth Sci Ctr Houston, Dept Anesthesia, McGovern Med Sch, Houston, TX 77030 USA
[4] Houston Methodist Hosp, Dept Surg, Houston, TX USA
[5] Houston Methodist Res Inst, Dept Pathol & Genom Med, Houston, TX USA
[6] Houston Methodist Hosp, Houston, TX USA
[7] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA
[8] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[9] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
关键词
Pediatric liver transplantation; Hepatic malignancies; UNOS; PEDIATRIC-ONCOLOGY-GROUP; HEPATOCELLULAR-CARCINOMA; HEPATOBLASTOMA; CHILDREN; CHEMOTHERAPY; SOCIETY; RESECTION; SURVIVAL; DATABASE; OUTCOMES;
D O I
10.1016/j.jpedsurg.2017.10.035
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background/purpose: The purpose of this study was to determine factors associated with patient and graft survival following orthotopic liver transplantation (OLT) in children and adolescents with primary hepatic malignancies. Methods: The United Network for Organ Sharing (UNOS) database was queried for all patients < 18 years old who received an OLT with a primary malignant liver tumor between 1987 and 2012 (n = 544). Five-year patient and graft survival were determined using Kaplan-Meier methodology, and independent predictors of survival were determined using multivariate Cox proportional hazards model. Results: The majority of patients were diagnosed with hepatoblastoma (HB) (n = 376, 70%) with 84 (15%) hepatocellular carcinoma (HCC) and 84 (15%) other. HCC patients were older, more often hospitalized at the time of transplant, and more likely to receive a cadaveric organ compared to HB patients. Five-year patient and graft survival for the entire cohort was 73% and 74%, respectively, with the majority of deaths owing to malignancy. On multivariate analysis, independent predictors of 5-year patient and graft survival included diagnosis, transplant era, and medical condition at transplant. Conclusions: In recent years, there has been significant improvement in posttransplant patient and graft survival for children and adolescents with primary hepatic malignancies. However, patients with HCC continue to have worse outcomes than those with other cancer types. Published by Elsevier Inc.
引用
收藏
页码:163 / 168
页数:6
相关论文
共 28 条
  • [1] Adrian R, PACKAGE BAYESIAN MOD
  • [2] [Anonymous], 2015, IPTA M
  • [3] [Anonymous], COG AHEP 0734 TREATM
  • [4] Austin MT, 2006, J PEDIATR SURG, V41, P182, DOI 10.1016/j.jpedsurg.2005.10.091
  • [5] Outcomes of transplantation in children with primary hepatic malignancy
    Beaunoyer, Mona
    Vanatta, Jason M.
    Oyihara, Makoto
    Strichartz, Debra
    Dahl, Gary
    Berquist, William E.
    Castillo, Ricardo O.
    Cox, Kenneth L.
    Esquivel, Carlos O.
    [J]. PEDIATRIC TRANSPLANTATION, 2007, 11 (06) : 655 - 660
  • [6] Liver Transplantation for Pediatric Hepatoblastoma and Hepatocellular Carcinoma Out of the Unknown
    Cheng, Elaine Y.
    Busuttil, Ronald W.
    [J]. JAMA SURGERY, 2015, 150 (12) : 1158 - 1159
  • [7] Analysis of national and single-center incidence and survival after liver transplantation for hepatoblastoma: New trends and future opportunities
    Cruz, Ruy J., Jr.
    Ranganathan, Sarangarajan
    Mazariegos, George
    Soltys, Kyle
    Nayyar, Navdeep
    Sun, Qing
    Bond, Geoffrey
    Shaw, Peter H.
    Haberman, Kimberly
    Krishnamurti, Lakshmanan
    Marsh, J. Wallis
    Humar, Abhinav
    Sindhi, Rakesh
    [J]. SURGERY, 2013, 153 (02) : 150 - 159
  • [8] Hepatocellular carcinoma in children: Results of the first prospective study of the International Society of Pediatric Oncology Group
    Czauderna, P
    Mackinlay, G
    Perilongo, G
    Brown, J
    Shafford, E
    Aronson, D
    Pritchard, J
    Chapchap, P
    Keeling, J
    Plaschkes, J
    Otte, JB
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (12) : 2798 - 2804
  • [9] Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy
    Czauderna, Piotr
    Lopez-Terrada, Dolores
    Hiyama, Eiso
    Haeberle, Beate
    Malogolowkin, Marcio H.
    Meyers, Rebecka L.
    [J]. CURRENT OPINION IN PEDIATRICS, 2014, 26 (01) : 19 - 28
  • [10] Epidemiology of primary hepatic malignancies in US children
    Darbari, A
    Sabin, KM
    Shapiro, CN
    Schwarz, KB
    [J]. HEPATOLOGY, 2003, 38 (03) : 560 - 566